Journal of Clinical Endocrinology & Metabolism, Vol 66, 465-472, Copyright © 1988 by Endocrine Society

ARTICLES

Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man

AM Richards, G Tonolo, P Montorsi, J Finlayson, R Fraser, G Inglis, A Towrie and JJ Morton
MRC Blood Pressure Unit, Western Infirmary, Glasgow, Scotland.

To investigate the effects of a small rise in the plasma atrial natriuretic peptide (ANP) concentration, 6 normal subjects received 2-h low dose (2 pmol/kg.min) infusions of both 28 [human alpha hANP-(99- 126)]- and 26 [human ANP-(101-126)]-amino acid peptides in a placebo- controlled study. Both peptides induced more than 2-fold increases in urinary sodium, calcium, and magnesium excretion. Effective renal plasma flow was slightly reduced, glomerular filtration rate did not change, and renal filtration fraction increased during the ANP infusions. Plasma renin, angiotensin II, and aldosterone concentrations fell by about 50%. Arterial blood pressure and plasma catecholamines did not change. Hematocrit and serum albumin concentrations rose significantly. ANP effects on urinary electrolytes and the renin- angiotensin-aldosterone system were sustained for over an hour after completion of the ANP infusions. The two peptides did not differ in their effects. These results are consistent with a physiological role for plasma ANP in the regulation of extracellular fluid volume and demonstrate that minor N-terminal truncation of alpha hANP has little effect on its biological activity.

This article has been cited by other articles:

				L. R. Potter, S. Abbey-Hosch, and D. M. Dickey Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions Endocr. Rev., February 1, 2006; 27(1): 47 - 72. [Abstract] [Full Text] [PDF]

				P.R Kalra, S.D Anker, A.D Struthers, and A.J.S Coats The role of C-type natriuretic peptide in cardiovascular medicine Eur. Heart J., June 2, 2001; 22(12): 997 - 1007. [PDF]

				G. B. Pidgeon, A. M. Richards, M. G. Nicholls, E. A. Espiner, T. G. Yandle, and C. Frampton Differing Metabolism and Bioactivity of Atrial and Brain Natriuretic Peptides in Essential Hypertension Hypertension, April 1, 1996; 27(4): 906 - 913. [Abstract] [Full Text]

				S. John, J. Krege, P. Oliver, Hagaman JR, J. Hodgin, S. Pang, T. Flynn, and O Smithies Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension Science, February 3, 1995; 267(5198): 679 - 681. [Abstract] [PDF]

				S. Shigematsu, T. Yamada, T. Aizawa, N. Takasu, and Z. Shimizu Differential Effects of Nifedipine on Plasma Atrial Natriuretic Peptide in Normal Subjects and Hypertensive Patients Angiology, January 1, 1992; 43(1): 40 - 46. [Abstract] [PDF]